Cargando…

Gamma delta T cells in hepatocellular carcinoma: Sunrise of new therapy based on Vδ2 T cells?

Detalles Bibliográficos
Autor principal:	Macek Jilkova, Zuzana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027155/ https://www.ncbi.nlm.nih.gov/pubmed/35451575 http://dx.doi.org/10.1002/ctm2.834

Ejemplares similares

Animal Models of Hepatocellular Carcinoma: The Role of Immune System and Tumor Microenvironment
por: Macek Jilkova, Zuzana, et al.
Publicado: (2019)

Commentary: Opportunity is like a sunrise. If you wait too long, you miss it
por: Reardon, Michael J.
Publicado: (2021)

Sunrise : a play in four acts /
por: Yu, Tsao 1957-
Publicado: (1978)

Percutaneous Ablation-Induced Immunomodulation in Hepatocellular Carcinoma
por: Dumolard, Lucile, et al.
Publicado: (2020)

Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges
por: Macek Jilkova, Zuzana, et al.
Publicado: (2019)

The Esplanade des particules at sunrise
por: Brice, Maximilien
Publicado: (2023)

COVID-19: thoughts at sunrise
por: Gasbarrini, Giovanni
Publicado: (2020)

Targeting Akt in Hepatocellular Carcinoma and Its Tumor Microenvironment
por: Mroweh, Mariam, et al.
Publicado: (2021)

Reply to Comment on “Jilkova, Z.M.; et al. Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges” Cancers 2019, 11, 1554
por: Macek Jilkova, Zuzana, et al.
Publicado: (2020)

SUNRISE-DI study. The daily sunrise is easier to predict than the benefit of adjuvant treatment in colon cancer
por: Carmona-Bayonas, A., et al.
Publicado: (2021)

Chitosan-based mucosal adjuvants: Sunrise on the ocean
por: Xia, Yufei, et al.
Publicado: (2015)

Antes del amanecer = Before sunrise
Publicado: (1995)

Sunrise deploys mobile network for CERN
Publicado: (2004)

Modulating the Crosstalk between the Tumor and Its Microenvironment Using RNA Interference: A Treatment Strategy for Hepatocellular Carcinoma
por: Mroweh, Mariam, et al.
Publicado: (2020)

Characterisation and induction of tissue-resident gamma delta T-cells to target hepatocellular carcinoma
por: Zakeri, Nekisa, et al.
Publicado: (2022)

Sunrise for new opportunities at ‘Carol Davila’ University of Medicine and Pharmacy
por: Popa, F
Publicado: (2010)

Chronic Intermittent Hypoxia Increases Cell Proliferation in Hepatocellular Carcinoma
por: Carreres, Lydie, et al.
Publicado: (2022)

International Study of Movement Behaviors in the Early Years (SUNRISE): Results from SUNRISE Sweden’s Pilot and COVID-19 Study
por: Delisle Nyström, Christine, et al.
Publicado: (2020)

Sunrise, Chatterton Falls, Quetico Provincial Park
por: Blacklock, Craig, et al.
Publicado: (2015)

Blocking of EphA2 on Endometrial Tumor Cells Reduces Susceptibility to Vδ1 Gamma-Delta T-Cell-Mediated Killing
por: Hudecek, Robert, et al.
Publicado: (2021)

New developments in ablation therapy for hepatocellular carcinoma: combination with systemic therapy and radiotherapy
por: Numata, Kauzshi, et al.
Publicado: (2022)

Vitamin D in midlife: The sunrise vitamin in the sunset of life
por: Kaushal, Manila Jain, et al.
Publicado: (2012)

Boost in radiotherapy: external beam sunset, brachytherapy sunrise
por: Maciejewski, Boguslaw
Publicado: (2009)

Circadian immunity, sunrise time and the seasonality of respiratory infections
por: Mo, Ziyi, et al.
Publicado: (2021)

Immune sunrise: from the immunome to the cancer immune landscape
por: Bindea, Gabriela, et al.
Publicado: (2022)

Microsaccades mediate perceptual alternations in Monet’s “Impression, sunrise”
por: Alexander, Robert G., et al.
Publicado: (2021)

Adoptive Cell Therapy in Hepatocellular Carcinoma: A Review of Clinical Trials
por: Ozer, Muhammet, et al.
Publicado: (2023)

PKCδ Blues for the β-Cell
por: Schmitz-Peiffer, Carsten, et al.
Publicado: (2010)

Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local
por: Pauza, C. David, et al.
Publicado: (2018)

Cancer stem cells in hepatocellular carcinomas
por: Das, Prasenjit, et al.
Publicado: (2015)

Analytic treatment of the two loop equal mass sunrise graph
por: Laporta, S., et al.
Publicado: (2004)

Immune checkpoints on T and NK cells in the context of HBV infection: Landscape, pathophysiology and therapeutic exploitation
por: Dumolard, Lucile, et al.
Publicado: (2023)

GNS561, a New Autophagy Inhibitor Active against Cancer Stem Cells in Hepatocellular Carcinoma and Hepatic Metastasis from Colorectal Cancer
por: Brun, Sonia, et al.
Publicado: (2021)

Immunologic Features of Patients With Advanced Hepatocellular Carcinoma Before and During Sorafenib or Anti-programmed Death-1/Programmed Death-L1 Treatment
por: Macek Jilkova, Zuzana, et al.
Publicado: (2019)

Revisit the signatures of γδ T cells in hepatocellular carcinoma
por: Gao, Yanan, et al.
Publicado: (2022)

Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma
por: Makkouk, Amani, et al.
Publicado: (2021)

Approach to systemic therapy in advanced hepatocellular carcinoma
por: Sankar, Kamya, et al.
Publicado: (2022)

New Biomarkers for Early Detection of Hepatocellular Carcinoma
por: Yoshida, Katsunori
Publicado: (2015)

On new physics in $\Delta \Gamma_d$
por: Bobeth, Christoph, et al.
Publicado: (2014)

Hepatocellular carcinoma therapy finds a channel on the radio
por: Camacho, Javier
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_la60ged5g15kln3k5j6f0228kt